SCHEMBL339124

SCHEMBL339124

CC1CCC2CC1(C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15466534 0.81 ALDH1A1 (0.31)
SCHEMBL5321209 0.78
SCHEMBL4738075 0.65
SCHEMBL19226217 0.63
SCHEMBL16673531 0.63
SCHEMBL135915 0.61
SCHEMBL5760574 0.61
SCHEMBL24654225 0.61
SCHEMBL8941059 0.61 GRIN2D (0.33)
Ammonia Solution, Strong SCHEMBL11341018 0.60 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383856-A1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2024-11-21 US claimed
CN-102060807-B Improved preparation process of pinaverium bromide LUNAN PHARM GROUP CORP 2012-11-07 CN claimed
CN-102060807-B Improved preparation process of pinaverium bromide LUNAN PHARM GROUP CORP 2012-11-07 CN disclosed
US-8202893-B2 Cannabinergic lipid ligands UNIVERSITY OF CONNECTICUT (US) 2012-06-19 US disclosed
US-8097752-B2 Antiprotozoal ring-substituted phospholipids MAKSCIENTIFIC, LLC (US) 2012-01-17 US disclosed
CN-102060807-A Improved preparation process of pinaverium bromide LUNAN PHARM GROUP CORP 2011-05-18 CN disclosed
CN-101394714-B Method for producing multilayered wiring substrate, multilayered wiring substrate, and electronic apparatus SEIKO EPSON CORP 2011-02-23 CN disclosed
US-7820144-B2 Receptor selective cannabimimetic aminoalkylindoles UNIVERSITY OF CONNECTICUT (US) 2010-10-26 US disclosed
US-20100234379-A1 Dual modulation of endocannabinoid transport and fatty-acid amide hydrolase for treatment of excitotoxicity CONNECTICUT, UNIVERSITY OF 2010-09-16 US disclosed
US-7589220-B2 Enzyme inhibitors for anandamide transporter and pharmacological use with urea, amide, thiourea or other groups UNIVERSITY OF CONNECTICUT (US) 2009-09-15 US disclosed
US-20090163557-A1 Cannabinergic Lipid Ligands NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-06-25 US disclosed
EP-1578754-A4 ANTIPROTOZOAL RING-SUBSTITUTED PHOSPHOLIPIDS MAKSCIENTIFIC LLC (US) 2006-07-19 EP disclosed
US-20060127802-A1 Positive working thermal plates ANOCOIL CORPORATION (US) 2006-06-15 US disclosed
US-20060105998-A1 Antiprotozoal ring-substiuted phospholipids MAK SCIENTIFIC CORPORATION (US) 2006-05-18 US disclosed
EP-1632236-A1 INHIBITORS OF THE ANANDAMIDE TRANSPORTER University of Connecticut (US) 2006-03-08 EP disclosed
EP-1578754-A2 ANTIPROTOZOAL RING-SUBSTITUTED PHOSPHOLIPIDS MakScientific Corporation (US) 2005-09-28 EP disclosed
US-20050074408-A1 Keto cannabinoids with therapeutic indications UNIVERSITY OF CONNECTICUT (US) 2005-04-07 US disclosed
US-20050020679-A1 Inhibitors of the anandamide transporter UNIVERSITY OF CONNECTICUT (US) 2005-01-27 US disclosed
WO-2004041167-A2 ANTIPROTOZOAL RING-SUBSTITUTED PHOSPHOLIPIDS CALOGEROPOULOU THEODORA (GR) 2004-05-21 WO disclosed
US-20040087590-A1 Novel biphenyl and biphenyl-like cannabinoids UNIVERSITY OF CONNECTICUT 2004-05-06 US disclosed